URIEL YAGUDAYEV: Open Payments
NPI 1598864647 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,689 in 43 payments from 17 companies in 2025. Trend: 2023 $812 · 2024 $1,641 · 2025 $1,689
Food & beverage: $1,689
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $396 |
| ABBVIE INC. | 5 | $332 |
| Amgen Inc. | 5 | $279 |
| Ardelyx, Inc. | 4 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Cumberland Pharmaceuticals, Inc. | 3 | $49 |
| PFIZER INC. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: DUPIXENT, QULIPTA, IBSRELA, LINZESS, KRYSTEXXA, REPATHA, Kerendia, GVOKE HYPOPEN.
Industry payments across NY — which companies pay providers there.
